| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytomx Therapeutics, Inc. (CTMX) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CTMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.95M | - | |
| Other | 650.0K | $2.60M | - | |
| CFO | 78.3K | $313.0K | - | |
| Other | 43.8K | $175.0K | - | |
| Dir | 38.0K | $152.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | Belvin Marcia51 | SVP, Chief Scientific Officer | Sale+OE | 4,181 | $1.23 | $5,138.87 | -2.3% | -30.4% | +58.9% | |
| Aug 20, 2024 | Rowland Lloyd A50 | General Counsel | Sale+OE | 4,181 | $1.23 | $5,138.87 | -3.1% | -30.4% | +58.9% | |
| Aug 20, 2024 | Ogden Christopher52 | Chief Financial Officer | Sale+OE | 1,984 | $1.23 | $2,438.53 | -1.8% | -30.4% | +58.9% | |
| Aug 20, 2024 | McCarthy Sean A.69 | CEO | Sale+OE | 13,898 | $1.23 | $17,082.03 | -2.1% | -30.4% | +58.9% | |
| Mar 19, 2024 | Rowland Lloyd A50 | General Counsel | Sell | 5,268 | $2.09 | $10,986.41 | -4.3% | -37.2% | -69.3% | |
| Mar 19, 2024 | McCarthy Sean A.69 | CEO | Sell | 20,223 | $2.09 | $42,175.07 | -3.7% | -37.2% | -69.3% | |
| Mar 19, 2024 | Ogden Christopher52 | SVP, Finance And Accounting | Sell | 2,971 | $2.09 | $6,196.02 | -3.4% | -37.2% | -69.3% | |
| Mar 19, 2024 | Belvin Marcia51 | SVP, Chief Scientific Officer | Sell | 12,795 | $2.09 | $26,683.97 | -7.1% | -37.2% | -69.3% | |
| Mar 19, 2024 | Landau Jeffrey B55 | Chief Business Officer | Sell | 6,562 | $2.09 | $13,685.05 | -5.6% | -37.2% | -69.3% | |
| Dec 20, 2023 | McCarthy Sean A.69 | CEO | Sell | 13,551 | $1.38 | $18,709.87 | -2.9% | +62.7% | -17.9% |